Alambic Investment Management, L.P. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 157 filers reported holding IMMUNOGEN INC in Q3 2016. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2018$264,000
+79.6%
25,081
+9.5%
0.04%
+105.6%
Q4 2017$147,000
-90.6%
22,912
-88.7%
0.02%
-89.4%
Q3 2017$1,558,000
+477.0%
203,597
+435.6%
0.17%
+415.2%
Q2 2017$270,000
+250.6%
38,015
+32.5%
0.03%
+83.3%
Q3 2016$77,000
-67.9%
28,700
-63.2%
0.02%
-70.0%
Q2 2016$240,00078,0000.06%
Other shareholders
IMMUNOGEN INC shareholders Q3 2016
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders